These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24630484)
1. Role of vitamin D derivatives in intestinal tissue of patients with inflammatory bowel diseases. Martinesi M; Ambrosini S; Treves C; Zuegel U; Steinmeyer A; Vito A; Milla M; Bonanomi AG; Stio M J Crohns Colitis; 2014 Sep; 8(9):1062-71. PubMed ID: 24630484 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients. Martinesi M; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG; Stio M Inflamm Bowel Dis; 2008 May; 14(5):597-604. PubMed ID: 18200516 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases. Martinesi M; Treves C; Bonanomi AG; Milla M; Bagnoli S; Zuegel U; Steinmeyer A; Stio M Clin Immunol; 2010 Jul; 136(1):51-60. PubMed ID: 20399147 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis. Stio M; Retico L; Annese V; Bonanomi AG Scand J Gastroenterol; 2016 Oct; 51(10):1193-9. PubMed ID: 27207502 [TBL] [Abstract][Full Text] [Related]
5. The novel vitamin D analog ZK191784 inhibits prostate cancer cell invasion. Stio M; Martinesi M; Simoni A; Zuegel U; Steinmeyer A; Santi R; Treves C; Nesi G Anticancer Res; 2011 Dec; 31(12):4091-8. PubMed ID: 22199266 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266 [TBL] [Abstract][Full Text] [Related]
7. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Souza HS; Elia CC; Spencer J; MacDonald TT Gut; 1999 Dec; 45(6):856-63. PubMed ID: 10562584 [TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Arihiro S; Ohtani H; Hiwatashi N; Torii A; Sorsa T; Nagura H Histopathology; 2001 Jul; 39(1):50-9. PubMed ID: 11454044 [TBL] [Abstract][Full Text] [Related]
9. TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent. Sasaki M; Ostanin D; Elrod JW; Oshima T; Jordan P; Itoh M; Joh T; Minagar A; Alexander JS Am J Physiol Cell Physiol; 2003 Feb; 284(2):C422-8. PubMed ID: 12388057 [TBL] [Abstract][Full Text] [Related]
11. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. Stio M; Martinesi M; Bruni S; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG Int Immunopharmacol; 2006 Jul; 6(7):1083-92. PubMed ID: 16714211 [TBL] [Abstract][Full Text] [Related]
12. Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: a comparative study of inflammatory bowel disease and colonic neoplasms. Vainer B; Horn T; Nielsen OH Scand J Gastroenterol; 2006 Mar; 41(3):318-25. PubMed ID: 16497620 [TBL] [Abstract][Full Text] [Related]
13. [The effects of 1alpha,25-dihydroxyvitamin D3 in regulation matrix metalloproteinase and tissue metalloproteinase inhibitors in human osteoblasts]. Guo LJ; Luo XH; Xie H; Zhou HD; Liao EY Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):125-8. PubMed ID: 15840226 [TBL] [Abstract][Full Text] [Related]
15. Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patients. Vrablicova Z; Soltys K; Krajcovicova A; Sturdik I; Koller T; Huorka M; Payer J; Stuchlik S; Killinger Z; Jackuliak P; Stuchlikova M; Drahovska H; Hlavaty T Bratisl Lek Listy; 2018; 119(7):408-415. PubMed ID: 30160128 [TBL] [Abstract][Full Text] [Related]
16. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. Kruidenier L; Kuiper I; Lamers CB; Verspaget HW J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014 [TBL] [Abstract][Full Text] [Related]
17. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Nakamura S; Ohtani H; Watanabe Y; Fukushima K; Matsumoto T; Kitano A; Kobayashi K; Nagura H Lab Invest; 1993 Jul; 69(1):77-85. PubMed ID: 7687311 [TBL] [Abstract][Full Text] [Related]
18. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023 [TBL] [Abstract][Full Text] [Related]
19. Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s. Binder MT; Becker E; Wiendl M; Schleier L; Fuchs F; Leppkes M; Atreya R; Neufert C; Atreya I; Neurath MF; Zundler S Inflamm Bowel Dis; 2018 May; 24(6):1237-1250. PubMed ID: 29788362 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]